|Bid||34.16 x 800|
|Ask||34.18 x 800|
|Day's Range||34.04 - 34.69|
|52 Week Range||15.21 - 34.98|
|Beta (5Y Monthly)||1.38|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 04, 2021|
|Forward Dividend & Yield||1.00 (2.96%)|
|Ex-Dividend Date||Nov 09, 2020|
|1y Target Est||35.30|
Concurrently Moody's has upgraded the ratings of the $1.6 billion senior secured term loans B1 and B3 due in 2024 and the $250 million senior secured revolving credit facility due in 2022, all co-borrowed by Alpha 3 B.V., Alpha US BidCo, Inc. and other entities to B1 from B2 and upgraded the rating of the $425 million senior unsecured notes due 2025, co-issued by Alpha 3 B.V. and Alpha US BidCo, Inc., to Caa1 from Caa2. A full list of affected ratings can be found at the end of this press release.
(Bloomberg) -- Three U.S. investment funds have been shortlisted in the next round of bidding for Hitachi Metals Ltd. as industrial conglomerate Hitachi Ltd. proceeds with its sale of the unit, according to people familiar with the matter.Bain Capital, Carlyle Group Inc. and KKR & Co. are poised to make separate offers, while the deadline for the second round of bids has been set for the middle of February, the people said, asking not to be identified because the talks are confidential. Public-private fund Japan Investment Corp. and Japan Industrial Partners Inc. are exploring teaming up with any of the funds, the people said.Hitachi has been acquiring and disposing of assets over the past few years as part of consolidation efforts. It exited a $26 billion U.K. nuclear power project in September, and previously bought out its high-tech unit, while selling its diagnostic-imaging business. The company had a 52.8% stake in Hitachi Metals as of March 31, representing, according to data compiled by Bloomberg.Shares of Hitachi Metals reversed losses to reach an intraday high a few minutes before the market close in Tokyo, rising as much as 1.5%. The company, which has a market value of 683 billion yen ($6.6 billion), makes products including specialty steel, rare earth magnets and electric wires.While Hitachi is considering various options to improve its corporate value, nothing has been decided and the company refrains commenting on individual deals, said spokesman Yuichi Izumisawa. Spokespeople for KKR, Bain, Carlyle and JIC declined to comment, while representatives for JIP weren’t immediately reachable.(Updates with share move in the fourth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
(Bloomberg) -- Adicon Clinical Laboratories Ltd., a Chinese lab operator backed by Carlyle Group Inc., is in talks with investors to raise a new round of funding before its planned initial public offering in Hong Kong, according to people familiar with the matter.BlackRock Inc., Malaysia’s Khazanah Nasional Bhd. and Mirae Asset (Hong Kong) are among investors that the company is discussing the fundraising with, the people said. Adicon is planning to raise at least $60 million in the new round which would value the business at more than $1 billion, said the people, who asked not to be identified as the information is private.Adicon has picked Jefferies Financial Group Inc. and Morgan Stanley to lead a Hong Kong IPO, which could raise about $400 million this year, Bloomberg News previously reported. The potential share sale will add to the boom of health-care listings in the Chinese city as companies look to capitalize on rallying stocks and surging investor interest due to the coronavirus pandemic.Founded in 2004, Adicon operates more than 20 diagnostic laboratories in China and has the capacity to run tests for more than 100,000 people a day, according to its website. Carlyle became the single largest shareholder of Adicon in 2018 when it teamed up with Meinian Onehealth Healthcare Holdings Co. to invest an unspecified amount.Deliberations for the latest funding round are ongoing, and size may change depending on investor demand, the people said. Representatives for Carlyle, Khazanah and Mirae Asset declined to comment, while representatives for Adicon and BlackRock didn’t immediately respond to requests for comment.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.